The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members
Abstract
This study provides new insights into neuroprotection involving interaction of protein kinase C (PKC) pathway with Bcl‐2 family proteins. Using a model of serum deprivation, we investigated the mechanism by which the anti‐Parkinson/monoamine oxidase (MAO)‐B inhibitor drug, rasagiline, exerts its neuroprotective effect in rat pheochromocytoma PC12 cells. Here, we report that rasagiline (0.1–10 µM) decreased apoptosis via multiple protection mechanisms, including the stimulation of PKC phosphorylation; up‐regulation of PKCα and PKCε mRNAs, induction of Bcl‐xL, Bcl‐w, and brain‐derived neurotrophic factor (BDNF) mRNAs; and down‐regulation of Bad and Bax mRNAs. Moreover, rasagiline inhibited the cleavage and activation of procaspase‐3 and poly (ADP‐ribose) polymerase (PARP), whereas the PKC inhibitor, GF109203X, reversed these actions. Similarly, rasagiline decreased serum‐free‐induced levels of the important regulator of cell death, Bad, which was also blocked by GF109203X, indicating the involvement of PKC in rasagiline‐induced cell survival. Furthermore, these studies have established that PKC‐ and Bcl‐2‐dependent neuroprotective activity of rasagiline is dependent on its propargyl moiety, because propargylamine had similar effects with the same potency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874
Cited by
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1883 · Cited by 1,363
Self-citationA Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
Olanow, C. W., Rascol, O., Hauser, R., Feigin, P. D., Jankovic, J., Lang, A., Langston, W., Melamed, E., Poewe, W., Stocchi, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809335 · Cited by 901
Brain Photobiomodulation Therapy: a Narrative Review
Salehpour, F., Mahmoudi, J., Kamari, F., Sadigh-Eteghad, S., Rasta, S. H., & Hamblin, M. R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0852-4 · Cited by 517
Murphy, E., Ardehali, H., Balaban, R. S., DiLisa, F., Dorn, G. W., Kitsis, R. N., Otsu, K., Ping, P., Rizzuto, R., Sack, M. N., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000104 · Cited by 458
Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders
Youdim, M. B. H., & Buccafusco, J. J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.11.007 · Cited by 380
Self-citation
Metadata
- Authors
- Weinreb, O., Bar‐Am, O., Amit, T., Chillag‐Talmor, O., & Youdim, M. B. H.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-07-09
- Volume
- 18
- Issue
- 12
- Pages
- 1471-1473
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2031843850
- Cited by
- 187
- References
- 3
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members. https://app.cochat.ai/papers/10.1096/fj.04-1916fje
- The paper
- Weinreb, O., Bar‐Am, O., Amit, T., Chillag‐Talmor, O., & Youdim, M. B. H. (2004). Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members. The FASEB Journal. https://doi.org/10.1096/fj.04-1916fje
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.